Translate this page into:
Emergence of human leptospirosis in Meghalaya, India: Clinical evidence from a hilly non-endemic region
*For correspondence: sandra.albert@iiphs.ac.in
-
Received: ,
Accepted: ,
Sir,
Leptospirosis is a zoonotic illness caused by the spirochete bacteria, Leptospira. It passes from infected animals to humans through contact with urine or with inoculated soil or water. The disease course often begins with a non-specific prodrome, which can progress to severe complications, such as Weil’s Syndrome, a triad of haemorrhage, jaundice, and acute kidney injury1. Other syndromes caused by leptospirosis are aseptic meningitis1, pulmonary hemorrhage2, myocarditis3 and more1. This range of manifestations makes it no surprise that general physicians may not initially suspect leptospirosis and delay initiation of the appropriate treatment4.
Although leptospirosis is classically associated with flooding and low-lying coastal environments5,6, relatively less importance is given to mountainous and non-coastal areas. The dominant feature of Meghalaya State is the Garo-Khasi-Jaintia range (features elevations of 1,200-1,800 m), a low mountain formation nestled in between Assam State and Bangladesh that gives its name to the main tribes and distinct regions of the State. The objective of this study was to provide an overview of risk factors, clinical presentations and disease course in this population as well as estimate the economic burden borne by the affected patients. When diagnosed early, leptospirosis can be managed with oral antibiotics in an uncomplicated and economical manner adds premise to this study as an alert to the presence of leptospirosis in Meghalaya and as a guide to prospective diagnosis for clinicians working here.
Ten patients diagnosed with leptospirosis and tested by IgM ELISA (Bio-Rad Evolis system and the Inbios Leptospira ELISA kit) received treatment between January and December 2023 in a tertiary care, charitable sector hospital in Shillong, the capital city of Meghalaya in the Northeast region of India. The study was initiated after obtaining approval from the Institutional Ethics Committee, Indian Institute of Public Health Shillong. Data was collected retrospectively from patient records and included patient demographics, symptoms, investigatory findings, comorbidities, treatment, clinical outcomes, and expenditure. Using standard operational definitions for critical care7, cases with hemodynamic instability or requiring ventilation were classified as severe and compared to those with mild to moderate illness.
This study consisted of one female and nine male patients, with a mean age of 27.1 (SD 7.9) yr. Occupation varied widely across the group, including daily wage labourers, office workers, and a farmer. The case summaries are described in supplementary table.
This study showed a range of syndromic presentations, with one patient presented with only fever and vomiting, while another presented with decreased urine output and altered sensorium in addition to fever. Some patients had notable physical examination findings such as icterus, abdominal tenderness, and bilateral renal angle tenderness. However, the characteristic finding of leptospirosis, conjunctival suffusion, was seen in one case.
Thrombocytopenia and leukopenia with neutrophilic predominance were present in most patients. Biochemical tests were significant for raised creatinine levels in half the cases. Elevated transaminases and markedly increased bilirubin levels accompanied jaundice in two cases, both showing characteristics of conjugated hyperbilirubinemia.
According to the severity criteria, four patients were categorized as severely affected by leptospirosis wherein all four were on inotrope infusions and required mechanical ventilation. The youngest patient was admitted to ICU having, in addition to acute kidney injury and hepatic insufficiency, severe anaemia and thrombocytopenia. Whereas table provides a comparison of the clinical and economic factors. In terms of clinical presentation, the sickest patients all had gastrointestinal manifestations, particularly abdominal pain, which the more moderately affected patients did not have.
| Category | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical presentation |
Fever myalgia Nausea/vomiting Abdominal pain Decreased urine output Lower limb paresis Malaise/loss of appetite |
Fever with chills Myalgia Nausea/vomiting Diarrhoea Burning Micturation Headache Malaise/loss of appetite |
Fever with chills Myalgia Nausea/vomiting Diarrhoea Abdominal pain Decreased urine output Cough, Malaise/loss of appetite |
Fever with chills Myalgia Decreased urine output Cough Malaise/loss of appetite |
Fever with chills Myalgia Abdominal pain Lower limb swelling Hiccups |
Fever with chills Myalgia Nausea/vomiting Diarrhoea Headache/Dizziness Loss of appetite |
Fever Nausea/Vomiting |
Fever with chills Myalgia Generalised rash Cough Malaise |
Fever Nausea/vomiting Diarrhoea Cough |
Fever with chills Nausea/vomiting Diarrhoea Abdominal pain Decreased urine Output Altered sensorium |
| Abnormal vitals on presentation |
BP: 102/52 mmHg SpO2: 94% |
BP: 97/50 mmHg HR: 112/min SpO2: 94% Temp: 102.7F |
HR: 121/min RR: 25/min |
HR: 100/min |
SpO2: 94% Temp: 101.5F |
SpO2: 92% Temp: 102F |
Nil significant | Temp: 104F |
HR: 114/min SpO2: 93% |
GCS: 7/15 BP: 75/51 mmHg HR: 132/min RR: 28/min GRBS: 12mg/dl |
| Significant examination findings | Icterus |
Mildly dehydrated Conjunctival suffusion |
Abdominal tenderness Bilateral renal angle tenderness |
Nil significant |
Icterus bilateral pedal oedema Abdominal tenderness |
Nil significant | Nil significant | Dehydrated | Dehydrated | Nil significant |
| Significant investigatory findings |
Hb: 5.4 g/dl PLT: 15,000/cumm Creat: 4.15 mg/dl TB: 27.57 mg/dl DB: 15.77 mg/dl Alb: 2.39 g/dl Amyl: 230 U/l Lipas: 197.9 U/l Urine RBC: Numerous Cast: Granular 3+ |
PLT: 140,000/cumm TC: 7500/cumm Neut: 89% Creat: 2.65 mg/dl Alb: 2.78 g/dl |
PLT: 140,000/cumm TC: 7300/cumm Neut: 87% Creat: 4.27 mg/dl TB: 2.67 mg/dl DB: 1.60 mg/dl Amyl: 321 U/l CXR:Patchy infiltrates Urine RBC: 24-26 Leuk: 8-10 |
TC: 4500/cumm Neut: 63% SGOT: 192.6 U/l SGPT: 194.9 U/l |
Hb: 7.7 g/dl TC: 2900/cumm Neut: 64% TB: 15.93 mg/dl DB: 7.55 mg/dl SGOT: 400.7 U/l SGPT: 323.8 U/l Lipase: 172.6 U/l APTT: 60.8 sec CXR: Right pleural effusion |
PLT: 123.000/cumm TC: 5700/cumm Neut: 73% SGOT: 65.9 U/l SGPT: 78.4 U/l |
TC:4000/cumm Neut: 66% SGOT: 215.2 U/l SGPT: 188.5 U/l |
PLT: 130,000/cumm TC: 4800/ cumm Neut: 81% SGOT: 61.1 U/l |
PLT: 144,000/cumm TC: 6900/ cumm Neut: 87% SGOT: 140.2 U/l SGPT: 125.3 U/l |
PLT: 66,000/cumm Creat: 2.72 mg/dl SGOT: 342.3 U/l SGPT: 155.0 U/l |
| Duration of symp. at presentation (days) | 3 | 4 | 3 | 12 | 7 | 4 | 3 | 6 | 7 | 15 |
| Duration of hospital admission (days) | 9 | 3 | 6 | 5 | 11 | 6 | 0 | 5 | 7 | 15 |
| Determinants of severe illness | Inotrope infusion ICU admission | None | Inotrope infusion ICU admission | None | Inotrope infusion | None | None | None | None |
Inotrope infusion ICU admission |
| Duration of ICU admission (days) | 2 | NA | 3 | NA | NA | NA | NA | NA | NA | 6 |
| Possible exposure to leptospira | None noted | Swimming outdoors | None noted | None noted | Swimming outdoors, Household rodent infestation | None noted | None noted | Household rodent infestation | None noted | Household rodent infestation |
| Outcome | Alive | Alive | Alive | Alive | Alive | Alive | Alive | Alive | Alive | Alive |
| Total direct cost incurred (INR) | 37,770 | 6,340 | 28,230 | 7,460 | 36,644 | 30,400 | 760 | 10,760 | 27,990 | 1,46,320 |
| Insurance coverage availed (INR) | 0 | 0 | 0 | 0 | 23,100 | 10,500 | 0 | 8,400 | 17,490 | 88,440 |
BP, blood pressure; HR, heart rate; Temp, temperature; RR, respiratory rate; DCLD, decompensated chronic liver disease; GCS, Glasgow coma scale; GRBS, general random blood sugar level, Hb, haemoglobin; PLT, platelet; Creat, creatine; TB, total bilirubin; DB, direct bilirubin; Alb, albumin; Amy, amylase; RBC, red blood cell; Neut, neutrophil; CXR, chest radiography; Leuk, leukocyte; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; ICU, intensive care unit; NA, not applicable, INR, Indian rupee
All the cases were presented to the hospital between August and December, the months adjacent to the monsoon. Possible exposure to Leptospira bacteria through contact with infected animal urine was specifically noted in only four cases, either through swimming in natural water bodies (1 case), by means of household rodent infestations (2 cases), or both (1 case). The diagnosis in all cases was clinical, and due to the lack of on-site testing capability, the confirmatory test was sent to a laboratory in Mumbai after the empirical initiation of appropriate antibiotics.
Median direct medical expenditure for the study duration was INR 28,110 (334 USD) [interquartile range (IQR) 7,180; 31,961], which included charges for laboratory tests, therapies, and mainly hospital stay, which averaged to 7.4 (SD: 3.7) days in duration. Half of the patients admitted to the hospital had some form of health insurance; however, on an average, only 60 per cent of the total amount was covered. Non-insured patients shouldered a median cost of nearly INR 7,460 (88 USD) (IQR: 3,550; 33,000).
Although Meghalaya is known for heavy rainfall, recent spatial analysis has shown that 99 per cent of the land area of the State is classified as low or very low susceptibility for flooding8. As stated previously, the main environmental risk factor associated with increased infections is flooding9. The floodwater is reportedly contaminated with microbiological organisms, becoming a source of infection and a vector transporting the microbes. On the basis of water saturation levels, pathogenic Leptospira can survive in soils and superficial river sediments at different depths and eventually be carried on to the surface water layer by erosion10. Elevation also plays an important role, as lower elevations tend to store rainwater, creating conditions favourable for Leptospira survival in freshwater11. With elevations ranging from 4,000 to 6,000 ft (1,220 to 1,830 m), the State of Meghalaya is an upland region characterised by mountainous terrains with rolling grasslands. Recent studies also underscore the fact that an increase in soil moisture brought on by flooding improves Leptospira survival in polluted areas12. Moist soil with neutral pH and other agroclimatic factors such as high rainfall and high-water table were found as major risk factors for leptospirosis13,14. Meghalaya is primarily composed of three main types of soil i.e., red loamy soils, lateritic soils, and alluvial soils, which have slightly acidic pH values15. Given the minimal prevalence of this main environmental risk factor, if leptospirosis is found in this State, it raises the question of previously unknown environmental factors that may predispose to the spread of the disease.
Previous studies have found high seropositivity in animals16,14 while human cases still remain underreported. Clinical under-recognition or misdiagnosis could be a key factor, as leptospirosis is frequently mistaken due to its non-specific symptoms for other causes of acute-febrile illnesses. In this study, the triad of jaundice, haemorrhage, and acute kidney injury that characterizes Weil’s Syndrome was apparent in at least two of the cases. Therefore, among the study participants, one fifth had features were suggestive of Weil’s Syndrome, whereas published literature shows that this classical 'icteric’ form was known to be found in only 5-10 per cent of leptospirosis cases17. The study was based on a tertiary hospital, which potentially skewed cases to those with more severe presentation.
This study intended to understand the risk factors, clinical picture and burden of leptospirosis on the affected patients, given the novelty of the disease in this region. Disease burden from a physiological point of view has been discussed; however, the economic burden of the disease also bears impact on the topic being discussed. Given that the National Pharmaceutical Pricing Authority sets the ceiling price for one capsule of 100 mg doxycycline at INR 3.08 (4¢ USD)18, the total cost of a course of treatment would be just over INR 40 (50¢ USD). Including consultation fees and the price of laboratory tests, the case in this series with the mildest illness only had a direct cost of INR760 (9 USD). Whereas cases needing admission had an average direct expenditure of nearly INR20,000 (240 USD), which excludes the indirect costs, such as for travel, accommodation, etc., considering the fact that many of these patients came referred from outside Shillong city for tertiary care. There is strong evidence that early initiation of antibiotics may prevent the development of major organ system failure, decreasing the severity and, consequently, economic impact of the disease1.
This study was constrained by the limited number of patients. Additional multicentric studies with a larger sample size are required to improve the generalisability of findings related to severity. Our study setting was a charitable hospital that aims to provide low-cost but high-quality care, further pointing out the challenges of having advanced diagnostic access in resource-limited settings. In this study, patients who presented with an acute febrile illness were subjected to a panel of diagnostic tests for common causes of acute fevers in the region. The patients included in the study were IgM ELISA positive for leptospirosis. PCR and MAT facilities were not available, as this was the first time that leptospirosis was being encountered in the State.
To our knowledge, this study for the first time confirmed the biological presence of Leptospira spp., although there have been no reports of human leptospirosis cases in Meghalaya, possibly due to a low index of suspicion among clinicians in hilly regions, which are historically thought to be non-conducive to leptospiral transmission. The diverse symptomatology observed among just these ten cases, highlights the complexity of diagnosing this potentially fatal infection and the need for inexpensive and rapid diagnostic facilities.
As the climate changes and increasingly frequent flooding besets the urbanized spaces in developing countries, recent studies report on the changing epidemiology of leptospirosis and its growing threat as a global public health concern. However, in the hills of Meghalaya, where floods are rare, there remain undiscovered and uncontrolled risk factors to this emerging zoonosis. This study, in a State without previously reported leptospirosis comes as an alert, seeking to trigger further research into prevalence and risk factors that are specific to hill geographies and raise the index of clinical suspicion among medical practitioners in the region.
Financial support & sponsorship
The first (DR) and second (BK) authors received financial support from the DBT/Wellcome Trust India Alliance Fellowship (grant number IA/CRTP(CRC)/20/1/600114), hosted at the Indian Institute of Public Health Shillong (IIPH-S).
Conflicts of Interest
None.
Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation
The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.
References
- Leptospirosis. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine (19th ed). New York: McGraw Hill; 2015. p. :1140-45.
- [Google Scholar]
- Global morbidity and mortality of leptospirosis: A systematic review. PLoS Negl Trop Dis. 2015;9:e0003898.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Infectious disease: leptospirosis. In: Innes JA, Walker BR, Hunter JAA, eds. Davidson’s Essentials of Medicine (2nd ed). London: Elsevier Health Sciences; 2015. p. :81-2.
- [Google Scholar]
- World Health Organization. Leptospirosis. Available from: https://www.paho.org/en/topics/leptospirosis, accessed on June 15, 2025.
- [Google Scholar]
- Environmental and behavioural determinants of leptospirosis transmission: a systematic review. PLoS Negl Trop Dis. 2015;9:e0003843.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Leptospirosis in India: a systematic review and meta-analysis of clinical profile, treatment and outcomes. Infez Med. 2023;31:290-305.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Guidelines for intensive care unit admission and discharge criteria 2023 Available from: https://dghs.mohfw.gov.in/uploads/assets/97vEqupMNx0un7XSHNaVuuynzg3YKRsj8tOQ9i3U.pdf, accessed on June 15, 2025
- GIS-based frequency ratio model for flood susceptibility zonation in the state of Meghalaya, Northeast India. Proc Indian Natl Sci Acad. 2024;90:1015-28.
- [CrossRef] [Google Scholar]
- Clinico epidemiological study of human leptospirosis in hilly area of South India-A population based case control study. Indian J Community Med. 2023;48:316-20.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Rainfall-driven resuspension of pathogenic Leptospira in a leptospirosis hotspot. Sci Total Environ. 2024;911:168700.
- [CrossRef] [PubMed] [Google Scholar]
- A systematic review of Leptospira in water and soil environments. PLoS One. 2020;15:e0227055.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Spatiotemporal dynamics and risk factors for human Leptospirosis in Brazil. Sci Rep. 2019;9:7000.
- [CrossRef] [PubMed] [Google Scholar]
- Spatial analysis of leptospira in rats, water and soil in Bantul district Yogyakarta Indonesia. Open J Epidemiol. 2015;5:22-31.
- [Google Scholar]
- Meghalaya [Homepage] Last updated on Nov 10, 2025. Available from: https://megagriculture.gov.in/Home.aspx, accessed on November 15, 2025
- [PubMed]
- Prevalence of leptospirosis among animal herds of north eastern provinces of India. Comp Immunol Microbiol Infect Dis. 2021;79:101698.
- [CrossRef] [PubMed] [Google Scholar]
- Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review. Eur J Clin Microbiol Infect Dis. 2020;39:835-46.
- [CrossRef] [PubMed] [Google Scholar]
- National Pharmaceutical Pricing Authority - Updated Price List. (2023) 2023 Available from: https://dc.kerala.gov.in/wp-content/uploads/2023/08/NPPA-Updated-Price-List-AS-ON-08-08-2023-1-1.pdf, accessed on June 15, 2025